Bank of New York Mellon’s MediciNova MNOV Stock Holding History

Bank of New York Mellon’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$103K	Hold	78,277	–	–	﹤0.01%	4196
2026 Q1	$107K	Sell	78,277 -17,897	-19%	-$27.1K	﹤0.01%	4093
2025 Q4	$126K	Hold	96,174	–	–	﹤0.01%	4090
2025 Q3	$122K	Hold	96,174	–	–	﹤0.01%	4088
2025 Q2	$126K	Hold	96,174	–	–	﹤0.01%	4053
2025 Q1	$140K	Hold	96,174	–	–	﹤0.01%	3959
2024 Q4	$202K	Hold	96,174	–	–	﹤0.01%	3945
2024 Q3	$202K	Hold	96,174	–	–	﹤0.01%	3901
2024 Q2	$138K	Buy	96,174 +2	+0%	+$3	﹤0.01%	3997
2024 Q1	$139K	Sell	96,172 -23,722	-20%	-$33.7K	﹤0.01%	3996
2023 Q4	$180K	Sell	119,894 -99	-0.1%	-$179	﹤0.01%	3980
2023 Q3	$251K	Sell	119,993 -163	-0.1%	-$379	﹤0.01%	3881
2023 Q2	$276K	Sell	120,156 -44	-0%	-$97	﹤0.01%	3871
2023 Q1	$260K	Hold	120,200	–	–	﹤0.01%	3810
2022 Q4	$246K	Sell	120,200 -48	-0%	-$106	﹤0.01%	3884
2022 Q3	$261K	Hold	120,248	–	–	﹤0.01%	3899
2022 Q2	$304K	Sell	120,248 -797	-0.7%	-$2.08K	﹤0.01%	3870
2022 Q1	$323K	Hold	121,045	–	–	﹤0.01%	3976
2021 Q4	$324K	Hold	121,045	–	–	﹤0.01%	4048
2021 Q3	$459K	Hold	121,045	–	–	﹤0.01%	3860
2021 Q2	$515K	Sell	121,045 -119,743	-50%	-$516K	﹤0.01%	3760
2021 Q1	$1.22M	Sell	240,788 -2,445	-1%	-$14.2K	﹤0.01%	3226
2020 Q4	$1.28M	Buy	243,233 +24,444	+11%	+$140K	﹤0.01%	3115
2020 Q3	$1.15M	Buy	218,789 +30,675	+16%	+$177K	﹤0.01%	3041
2020 Q2	$1.02M	Buy	188,114 +28,684	+18%	+$152K	﹤0.01%	3107
2020 Q1	$593K	Sell	159,430 -112	-0.1%	-$583	﹤0.01%	3269
2019 Q4	$1.08M	Buy	159,542 +3,912	+3%	+$29.4K	﹤0.01%	3213
2019 Q3	$1.24M	Buy	155,630 +1,174	+0.8%	+$10.5K	﹤0.01%	3044
2019 Q2	$1.49M	Buy	154,456 +1,227	+0.8%	+$12.9K	﹤0.01%	2980
2019 Q1	$1.27M	Sell	153,229 -95	-0.1%	-$829	﹤0.01%	3024
2018 Q4	$1.25M	Buy	153,324 +590	+0.4%	+$5.89K	﹤0.01%	2985
2018 Q3	$1.91M	Buy	152,734 +1,125	+0.7%	+$11.3K	﹤0.01%	2862
2018 Q2	$1.21M	Buy	151,609 +25,554	+20%	+$264K	﹤0.01%	3145
2018 Q1	$1.29M	Buy	126,055 +19,291	+18%	+$192K	﹤0.01%	3067
2017 Q4	$691K	Sell	106,764 -7,868	-7%	-$52.2K	﹤0.01%	3450
2017 Q3	$730K	Sell	114,632 -216	-0.2%	-$1.15K	﹤0.01%	3405
2017 Q2	$604K	Sell	114,848 -2,176	-2%	-$12.2K	﹤0.01%	3514
2017 Q1	$701K	Buy	117,024 +369	+0.3%	+$2.22K	﹤0.01%	3417
2016 Q4	$704K	Buy	116,655 +290	+0.2%	+$2.04K	﹤0.01%	3442
2016 Q3	$871K	Buy	116,365 +517	+0.4%	+$3.48K	﹤0.01%	3245
2016 Q2	$875K	Buy	115,848 +64,167	+124%	+$464K	﹤0.01%	3235
2016 Q1	$379K	Buy	+51,681	New	+$256K	﹤0.01%	3549

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

FPAS

Focus Partners Advisor Solutions Saint Louis, Missouri $11.8B AUM 25.68% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Bank of New York Mellon's MNOV Position: Q2 2026 in Review

Bank of New York Mellon held its MediciNova (MNOV) position steady in Q2 2026 at 78,277 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #4196.

Bank of New York Mellon first reported a position in MNOV in Q1 2016 and has held it in 42 quarters since. The position peaked at $1.91M in Q3 2018. 9 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.

Bank of New York Mellon held 78,277 shares of MediciNova worth $103K as of Q2 2026.
Bank of New York Mellon left its MediciNova share count unchanged in Q2 2026.
MediciNova made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4196 holding.
Bank of New York Mellon first reported a position in MediciNova in Q1 2016 and has held it in 42 quarters since.
Bank of New York Mellon's MediciNova position peaked at $1.91M in Q3 2018.
9 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.